TY - JOUR
T1 - Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells
AU - Acott, Philip
AU - O'Regan, Patrick A.
AU - Crocker, John F.S.
PY - 2009/2
Y1 - 2009/2
N2 - Consensus is lacking about which immunosuppressant agents potentiate BK virus infection. The effects of mycophenolic acid (MPA) were investigated in BK virus (BKV)-infected Vero E6 cells. MPA (1-16 mg/l) exhibited a dose-dependent anti-viral effect (101-104 fold reduction in BKV DNA copies/ml) in supernatant, similar to cidofovir (2.5-25 mg/l). This effect was observed for early and persistent infection, and infection with noncoding control region (NCCR) rearranged BKV. MPA reduced BKV DNA copies/ml by >1 log after day 14 in three patient isolates before and after NCCR rearrangement, and in cells. MPA reduced total cellular protein levels, consistent with an anti-metabolite effect without increased cytopathic activity. BKV infection was associated with a transient, significant reduction of collagen 1A1 on day 7 but not on days 14, 21, and 28 or in the presence of MPA. Reduction of alpha smooth muscle actin mRNA was observed only in the BKV + MPA group, and only on day 7. There was no significant alteration of heat shock protein 47 or transforming growth factor-β mRNA expression. These in vitro data suggest that MPA may have a protective, anti-viral effect in BKV-infected renal tubular cells with an anti-viral response. Maintaining, or even increasing, the MPA dose should be evaluated for reduction of BKV viremia levels.
AB - Consensus is lacking about which immunosuppressant agents potentiate BK virus infection. The effects of mycophenolic acid (MPA) were investigated in BK virus (BKV)-infected Vero E6 cells. MPA (1-16 mg/l) exhibited a dose-dependent anti-viral effect (101-104 fold reduction in BKV DNA copies/ml) in supernatant, similar to cidofovir (2.5-25 mg/l). This effect was observed for early and persistent infection, and infection with noncoding control region (NCCR) rearranged BKV. MPA reduced BKV DNA copies/ml by >1 log after day 14 in three patient isolates before and after NCCR rearrangement, and in cells. MPA reduced total cellular protein levels, consistent with an anti-metabolite effect without increased cytopathic activity. BKV infection was associated with a transient, significant reduction of collagen 1A1 on day 7 but not on days 14, 21, and 28 or in the presence of MPA. Reduction of alpha smooth muscle actin mRNA was observed only in the BKV + MPA group, and only on day 7. There was no significant alteration of heat shock protein 47 or transforming growth factor-β mRNA expression. These in vitro data suggest that MPA may have a protective, anti-viral effect in BKV-infected renal tubular cells with an anti-viral response. Maintaining, or even increasing, the MPA dose should be evaluated for reduction of BKV viremia levels.
UR - http://www.scopus.com/inward/record.url?scp=58149277053&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58149277053&partnerID=8YFLogxK
U2 - 10.1111/j.1432-2277.2008.00766.x
DO - 10.1111/j.1432-2277.2008.00766.x
M3 - Article
C2 - 18855849
AN - SCOPUS:58149277053
SN - 0934-0874
VL - 22
SP - 225
EP - 231
JO - Transplant International
JF - Transplant International
IS - 2
ER -